SNV-1

N/A

Report date: 2025/09/25 17:32:40

Base Information

Drug NameSNV-1
Drug Alias NameSuperNova-1SN-V1cSupernova 1SNV1SN-V1sa +[7] 
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyBiologics > Oncolytic virus
Mechanisms of ActionCell death stimulantsImmunostimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumoursTriple Negative Breast NeoplasmsSquamous Cell Carcinoma of Head and Neck +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCalidi Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCalifornia Institute For Regenerative MedicineCalidi Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursTriple Negative Breast NeoplasmsSquamous Cell Carcinoma of Head and Neck +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A